Patent · US Expired

Modulators and modulation of the interaction between RGM and Neogenin

US7771952B2 · kind B2 · utility

8Cited by

6References

2Claims

0Family size

Assignee

Abott Laboratories · US

Inventors

Stephen M. Strittmatter · Durham, US
Bernhard Mueller · Neustadt, DE
Lutz Deitinghoff · Ludwigshafen, DE

Key dates

Filing date	Jun 26, 2003
Grant date	Aug 10, 2010
Priority date	—
Expiry date	Jul 20, 2023

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S530/839
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

This invention relates to drug screening using mammalian repulsive guidance molecules and mammalian Neogenin. In addition, the invention provides for methods of preventing, alleviating or treating various disorders of the nervous system, angiogenic disorders or disorders of the cardio-vascular system and malignancies of different etiology by disrupting the interaction between RGM and Neogenin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.